Kidney Cancer

Thursday, March 22, 2018 - 11:46am
Results from the CheckMate 214 clinical trial show that combined therapy with two immunotherapy drugs, nivolumab and ipilimumab, can be very effective in the treatment of renal cell carcinoma, the most common type of kidney cancer.
Friday, March 16, 2018 - 10:00am
Kidney cancer kills about 14,000 people every year. It is especially deadly when it is found in the late stages. Scott was first diagnosed with kidney cancer in January of 2011 and given only 10 months to live...that was 7 years ago.
Tuesday, May 23, 2017 - 4:03pm

Ten years ago, patients diagnosed with advanced-stage kidney cancer had few options, and none of them were very promising. But in recent years, we have seen a revolution in kidney cancer treatment with ten new targeted drugs winning FDA approval.

Tuesday, June 24, 2014 - 12:00pm
As Immunotherapy Awareness Month winds down, we want to highlight three different clinical trials being led by physicians at our Center for Immunotherapy of novel immunotherapy approaches for treating genitourinary cancers.
Friday, February 21, 2014 - 12:20pm

My husband, Brian Townson was in his 60s when he learned that he had collecting duct renal carcinoma (CDC), a rare and very aggressive form of kidney cancer that is usually diagnosed after it has spread to other parts of the body.

Friday, May 17, 2013 - 2:51pm

When it comes to kidney cancer, there has been more promising news as of late. Treatments for the disease have changed dramatically over the past few years.

Tuesday, March 26, 2013 - 7:31am

Until recently, radiation therapy has played a very limited role in the treatment of kidney tumors.